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Abstract 
Purpose: To investigate the anti-depressant activity of kaempferol, quercetin, kaempferol-3-O-β-D-
glucose and quercetin-3-O-β-D-glucose isolated from Apocynum venetum Linn. (Apocynaceae) leaf and 
their mechanisms of action. 
Methods: The four flavonoids were isolated from Apocynum venetum leaf by chromatography. Mice 
were divided into vehicle, fluoxetine, kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-
3-O-β-D-glucose groups (n = 10).  Forced swimming (FST), tail suspension (TST) and locomotor activity 
(LAT) tests were used to evaluate the effects of the four flavonoids (0.35 mM/kg) on immobility time, 
monoamine neurotransmitters, viz, norepinephrine (NE), dopamine (DA) and 5-hydroxytryptamine (5-
HT), as well as on the metabolite (5-HIAA) in mice brain and central nervous system (CNS) with the aid 
of video camera, HPLC-ECD and activity-monitoring system. 
Results: The four flavonoids significantly (p < 0.05) reduced mice immobility time (72.58 - 90.24; 52.58 
- 70.24 s), 5-HIAA levels (940.8 - 1244.7; 880.8 - 1164.1 ng/g) and 5-HIAA/5-HT ratio (1.77 - 4.76; 1.83 
- 4.16), but increased NE, DA and 5-HT levels (238.7 - 405.7, 308.4 - 528.1, 261.4 - 531.9; 243.9 - 
423.6, 296.7 - 534.9, 279.8 - 481.4 ng/g) in FST and TST, compared with control group (146.18, 126.18 
s; 1363.4, 1240.9 ng/g; 7.43, 6.16; 138.4, 235.4, 183.4 and 143.7, 218.6, 201.4 ng/g). The effects of the 
four flavonoids on the above indices were significant (p < 0.05) and positively related to their polarity. 
They had no CNS-stimulating effects in LAT. 
Conclusion: The anti-depressant activities of the four flavonoids are positively related to their polarity, 
and the mechanisms may be due to increased NE, DA and 5-HT and reduced 5-HT metabolism. 
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Depression is a kind of mental disorders and its 
major symptoms include the reduced interest and 
pleasure, lowered mood and metabolic disorder 
of monoamine neurotransmitters in the central 
nervous system (CNS) [1]. World Health 
Organization (WHO) predicted that depression 
will be the second most common disease in 2020 
[2]. 
 
Apocynum venetum Linn. (Apocynaceae family) 
is widely distributed in many provinces of China 
such as Xinjiang, Gansu, Shandong and Hebei 
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[3]. It’s reported that A. venetum leaf has lots of 
pharmacological effects such as anti-oxidant 
[4,5], anti-hypertensive [6], anti-depressant [7] 
and anti-anxiety activities [8]. A series of studies 
[9-14] suggested that the active constituents of 
anti-depressant activity of A. venetum leaf are 
total flavonoids. The flavonoids of A. venetum 
leaf include tamarixetin, kaempferol, quercetin, 
hyperoside, trifolin, quercetin-3-O-(6"-O-
malonyl)-β-D-glucose, kaempferol-3-O-β-D-
glucose, quercetin-3-O-β-D-glucose, rutin, etc 
[15,16]. Although it is reported that quercetin and 
kaempferol have significant anti-depressant 
activities [17,18], differences in their anti-
depressant activities as well as possible 
mechanisms still need further investigation. 
Thus, the main aim of the present study was to 
evaluate the differences in the anti-depressant 
activities of quercetin, quercetin-3-O-β-D-
glucose, kaempferol and kaempferol-3-O-β-D-






A. venetum leaves were purchased from Chinese 
herbal medicine market of Xian in 2013, 
identified by Jun-Lian Lang. A voucher specimen 
(voucher no. BJHLGH20130164) was stored in 
pharmacy department of Beijing Huilongguan 
Hospital for future reference. 
 
Chemicals and reagents 
 
Analytical grade ethanol, methanol, chloroform, 
petroleum ether, ethyl acetate, n-butyl alcohol 
and silica gel were obtained from Qingdao 
Haiyang Chemical Co., Ltd. (Qingdao, China) 
and Sephadex LH-20 was purchased from H&E 
Co., Ltd (Beijing, China). HPLC grade methanol 
was purchased from Fisher (Fisher Scientific, 
Germany). Fluoxetine-HCl was obtained from 
Lilly (Lilly, USA, purity > 98 %). NE, DA, 5-HT, 5-
HIAA and dihydroxy-benzoic acid (DHBA) were 





Male mice (20 ± 2 g) were purchased from the 
SLRC Laboratory Animal Company (Shanghai, 
China). The animals were conditioned to 
standard laboratory conditions (12/12 h light 
/dark cycle at 25 ± 1 °C) and had free access to 
food and water. All experiments were strictly in 
accordance with the international guidelines for 
care and use of laboratory animals [19]. The 
experiments were carried out with the approval of 
the Animal Care and Use Committee of Beijing 
Huilongguan Hospital (protocol no: BJHLGH 
ACUC2013). 
 
Extraction and isolation 
 
The air-dried A. venetum leaves (10 kg) were 
finely cut and extracted with 75 % ethanol by 
percolation method at the speed of 20 mL/min. 
The 75 % ethanol solvent was combined and 
concentrated under vacuum to afford a crude 
extract (1.2 kg), which was then suspended in 
hot water and successfully partitioned with 
petroleum ether, ethyl acetate and n-butyl 
alcohol. The ethyl acetate fraction (180 g) was 
subjected to column chromatography (CC) over 
silica gel (74 - 149 μm), eluted with chloroform-
methanol and chloroform-methanol-water to 
obtain nine fractions. Fraction 2 (32.2 g) was 
separated by CC over silica gel (chloroform-
methanol) and purified on Sephadex LH-20 
(chloroform-methanol) to provide compounds 
kaempferol (98 mg) and quercetin (173 mg). 
Fraction 5 (28.9 g) was separated by CC over 
silica gel (chloroform-methanol-water) and 
purified on Sephadex LH-20 (chloroform-
methanol-water) to provide compounds 
kaempferol-3-O-β-D-glucose (67 mg) and 
quercetin-3-O-β-D-glucose (173 mg). The 
structures of the four compounds were identified 
by nuclear magnetic resonance (NMR) data, 
compared with the existing literatures [15,16], 
and their purities were more than 98 %, verified 
by area normalization method of high 
performance liquid chromatography with 
electrochemical detector (HPLC-ECD). Their 
chemical structures are shown in Figure 1. 
 
Grouping and drug treatment 
 
Mice were randomly divided into 6 groups (n = 
10): negative control, positive control, 
kaempferol, quercetin, kaempferol-3-O-β-D-
glucose and quercetin-3-O-β-D-glucose groups. 
Fluoxetine, kaempferol, quercetin, kaempferol-3-
O-β-D-glucose and quercetin-3-O-β-D-glucose 
were separately dissolved in 0.5 % CMC-Na to 
obtain 2 mM fluoxetine, 35 mM kaempferol, 35 
mM quercetin, 35 mM kaempferol-3-O-β-D-
glucose and 35 mM quercetin-3-O-β-D-glucose. 
The vehicle solvent (0.5 % CMC-Na) and 
fluoxetine served as negative control and positive 
control groups, respectively. The doses of 
fluoxetine, kaempferol, quercetin, kaempferol-3-
O-β-D-glucose and quercetin-3-O-β-D-glucose 
for mouse were 0.2, 0.35, 0.35, 0.35 and 0.35 
mM/kg, respectively. The vehicle and drugs were 
intraperitoneally administered at volume of 0.1 
mL/10 g 60 min prior to the test session. 
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Figure 1: Chemical structure of kaempferol (1), quercetin (2), kaempferol-3-O-β-D-glucose (3) and quercetin-3-
O-β-D-glucose (4); polarity: 1 < 2 < 3 < 4 
 
Forced swimming test (FST) 
 
FST was carried out on mice according to the 
existing method with some modifications 
[18,20,21]. Mice were individually placed into 
glass cylinders (height 25 cm, diameter 10 cm), 
which were filled with water (temperature: 25 ± 1 
°C; depth: 18 cm). Twenty-four hours after the 
pretest, mice were forced to swim in the glass 
cylinders for 6 min. After 2 min swimming, the 
duration of immobility was recorded during the 
remaining 4 min using a video camera. Mice 
were judged to be immobile when no additional 
activity was observed other than that those 
movements necessary to keep its head above 
the water. Additionally, the observer recording 
the immobility of mice was blinded to the drug 
treatments and after each test, the glass 
cylinders was refilled with fresh water. 
 
Tail suspension test (TST) 
 
TST was carried out on mice according to the 
existing method with some modifications [22]. 
Briefly, each mouse was individually suspended 
by the tail (20 mm from the end) for 6 min in a 
box (250 × 250 × 300 mm3) with the head 50 mm 
from the bottom. Testing was carried out in a 
darkened room with minimal background noise. 
The duration of immobility was recorded during 
the final 4 min of the test using a video camera. 
Mice were judged to be immobile only when they 
were passively hanged and completely 
motionless. Additionally, the observer recording 
the immobility of mice was blinded to the drug 
treatments. 
Locomotor activity test (LAT) 
 
To access the effects of drugs on locomotor 
activity, mice were individually placed into 
cylinders (height 25 cm, diameter 15 cm) at the 
same time 60 min after drug administration and 
then the total locomotor activity of each mouse 
was automatically measured and recorded in 5 
min separately by an activity-monitoring system 
(Institute of Materia Medica, Chinese Academy of 
Medical Sciences) [1]. 
 
Determination of monoamine 
neurotransmitter and metabolite 
 
The neurotransmitter concentrations in mice 
brain were simultaneously determined according 
to the existing method with some modifications 
[23]. The vehicle group (negative control group) 
without any stress was added as vehicle-stress 
group in this part. After the FST and TST were 
completed, mice were sacrificed by decapitation 
in the animal laboratory, and their brain tissues 
were immediately obtained on ice and stored at -
80 °C until biochemistry assay. The brain tissue 
of each mouse was homogenized in ice-cold 
0.02 M perchloric acid including 1.0 μM DHBA 
(internal standard). Then the homogenates were 
centrifuged at 14000 rpm for 15 min at 4 °C, and 
the supernatant was separated and filtered 
through a 0.22 μm membrane filter prior to HPLC 
analysis. The HPLC analysis was carried out on 
Agilent 1200 (Ageilent, USA), equipped with ECD 
(Model 5300A CoulArray Detector) and 
connected to an Agilent ChemStation. The 
chromatography was performed on a Diamonil 
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C18 column (4.6 mm × 25 mm, 5 μm). The 
mobile phase consisted of 11% methanol and 0.1 
M NaH2PO4 aqueous solution including 0.5 mM 
EDTA•Na2 and 0.85 mM OSA. The pH of mobile 
phase was adjusted to 3.4 using phosphate acid. 
Then mobile phase were filtered through 0.22 μm 
membrane prior to HPLC analysis. The flow rate, 
injection volume, column temperature and 
working potential were 0.8 mL/min, 20 μL, 25 °C 
and +80 mV, respectively. The quantifications of 
NE, DA, 5-HT and 5-HIAA in sample were 
analyzed by standard curve method. Additionally, 
the levels of NE, DA, 5-HT and 5-HIAA were 




All data are presented as mean ± standard error 
of the mean (SEM, n = 10). One-way ANOVA 
(LSD test) was used to analyze differences 
among different groups on SPSS (version 20.0). 
Differences were recognized as statistically 




Effects of four flavonoids on duration of 
immobility 
 
As shown in Figures 2 and 3, after treatment with 
fluoxetine at dose of 0.2 mM/kg, the duration of 
immobility (58.9 and 38.59 sec) in FST and TST 
was significantly (p < 0.05) reduced, compared 
with the vehicle group (146.18 and 126.18 sec), 
and the results indicated that the FST and TST 
models were successfully established. After 
treatment with kaempferol, quercetin, 
kaempferol-3-O-β-D-glucose or quercetin-3-O-β-
D-glucose at dose of 0.35 mM/kg, the duration of 
immobility (72.58 - 90.24 and 52.58 - 70.24 sec) 
was significantly (p < 0.05) reduced in FST and 
TST, compared with the vehicle group (146.18 
and 126.18 sec). Moreover, the inhibitory effects 
of the four flavonoids on the duration of 
immobility in FST and TST were significantly (p < 




Effects of four flavonoids on locomotor 
activity 
 
As shown in Figure 4, the locomotor activity 
counts did not show any significant differences 
among the vehicle, fluoxetin, kaempferol, 
quercetin, kaempferol-3-O-β-D-glucose and 
quercetin-3-O-β-D-glucose groups. The results 
suggested that the effects of drug treatments on 
the reductions of immobility time in FST and TST 






Figure 2: Effects of kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-3-O-β-D-glucose on the 
duration of immobility in FST; ap < 0.05 vs. the vehicle group, bp < 0.05 vs. the kaempferol group, cp < 0.05 vs. 
the quercetin group, dp < 0.05 vs. the kaempferol-3-O-β-D-glucose group 
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Figure 3: Effects of kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-3-O-β-D-glucose on the 
duration of immobility in TST; ap < 0.05 vs. the vehicle group, bp < 0.05 vs. the kaempferol group, cp < 0.05 vs. 
the quercetin group, dp < 0.05 vs. the kaempferol-3-O-β-D-glucose group 
 
 
Figure 4: Effects of kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-3-O-β-D-glucose on 
locomotor activity of mice 
 
Effect of four flavonoids on monoamine 
neurotransmitter and metabolite 
 
The quantifications of monoamine 
neurotransmitter and metabolite concentrations 
in sample were evaluated according to the 
standard curves of NE (y = 0.045800x+0.003712, 
r=0.9999), DA (y=0.054806x+0.006300, 
r=0.9998), 5-HT (y=0.048102x+0.001102, 
r=0.9994) and 5-HIAA (y=0.050893x+0.004106, 
r=0.9999). The chromatogram of standard 
substances and sample are shown in Figure 5. 
The effects of drug treatments on the levels of 
NE, DA, 5-HT and 5-HIAA in FST and TST are 
presented in Tables 1 and 2. The effects of drug 
treatments on the ratio of 5-HIAA/5-HT in FST 
and TST are shown in Figures 6 and 7. 
Compared with the vehicle-stress group, the 
levels of NE, DA, 5-HT of vehicle group were 
significantly (p < 0.05) reduced in FST and TST, 
and the level of 5-HIAA and the ratio of 5-
HIAA/5-HT of vehicle group were significantly (p 
< 0.05) increased in FST and TST. After 
treatment with fluoxetin at dose of 0.2 mM/kg, the 
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levels of NE, DA and 5-HT were significantly (p < 
0.05) increased in FST and TST, compared with 
the vehicle group, and the level of 5-HIAA and 
the ratios of 5-HIAA/5-HT were significantly (p < 
0.05) reduced in FST and TST, compared with 
the vehicle group. The results of the vehicle-
stress, vehicle and fluoxetin groups indicated that 
the FST and TST models were successfully 
established. After treatment with kaempferol, 
quercetin, kaempferol-3-O-β-D-Glucose or 
quercetin-3-O-β-D-glucose at dose of 0.35 
mM/kg, the levels of NE, DA and 5-HT were 
significantly (p < 0.05) increased in FST and 
TST, compared with the vehicle group, and the 
level of 5-HIAA and the ratios of 5-HIAA/5-HT 
were significantly (p < 0.05) reduced in FST and 
TST, compared with the vehicle group. 
Moreover, the reversed effects of the four 
flavonoids on the levels of NE, DA, 5-HT and 5-
HIAA and the ratio of 5-HIAA/5-HT were 
significantly (p < 0.05) different in FST and TST 
(kaempferol < quercetin < kaempferol-3-O-β-D-
glucose < quercetin-3-O-β-D-glucose). 
 
Table 1: Effects of kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-3-O-β-D-glucose on the 
levels of NE, DA, 5-HT and 5-HIAA in FST 
 
Group NE (ng/g) DA (ng/g) 5-HT (ng/g) 5-HIAA (ng/g) 
Vehicle 138.4±9.8 235.4±43.1 183.4±12.4 1363.4±47.2 
Fluoxetine 463.2±24.9a 640.1±52.8a 479.3± 4.7a 835.5±45.6a 
Kaempferol 238.7±35.6a 308.4±34.2a 261.4±20.4a 1244.7±41.2a 
Quercetin 312.4±47.1a,b 391.0±23.5a,b 387.6±18.5a,b 1128.9±54.6a,b 
Kaempferol-3-O-β-D-glucose 358.1±39.5a,b,c 469.4±25.7a,b,c 467.2±30.1a,b,c 1054.4±54.7a,b,c 
Quercetin-3-O-β-D-glucose 405.7±41.2a,b,c,d 528.1±23.8a,b,c,d 531.9±25.7a,b,c,d 940.8±50.3a,b,c,d 
Vehicle-stress 512.4±30.2a 654.8±34.7a 645.7±52.4a 808.9±32.1a 
ap < 0.05 vs. the vehicle group, bp < 0.05 vs. the kaempferol group, cp < 0.05 vs. the quercetin group, dp < 0.05 
vs. the kaempferol-3-O-β-D-glucose group 
 
Table 2: Effects of kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-3-O-β-D-glucose on the 
levels of NE, DA, 5-HT and 5-HIAA in TST 
 
Group NE (ng/g) DA (ng/g) 5-HT (ng/g) 5-HIAA (ng/g) 
Vehicle 143.7±11.2 218.6±32.5 201.4±23.7 1240.9±56.3 
Fluoxetine 441.8±19.4a 596.1±46.7a 498.5± 34.1a 838.5±38.9a 
Kaempferol 243.9±26.1a 296.7±26.1a 279.8±23.2a 1164.1±58.2a 
Quercetin 298.4±37.5a,b 388.6±30.3a,b 321.3±29.5a,b 1040.9±45.7a,b 
Kaempferol-3-O-β-D-glucose 368.7±20.2a,b,c 473.1±31.2a,b,c 391.6±38.6a,b,c 962.4±40.1a,b,c 
Quercetin-3-O-β-D-glucose 423.6±28.8a,b,c,d 534.9±35.3a,b,c,d 481.4±45.5a,b,c,d 880.8±39.3a,b,c,d 
Vehicle-stress 512.4±30.2a 637.5±54.6a 645.7±52.4a 897.9±52.1a 
ap < 0.05 vs. the vehicle group, bp < 0.05 vs. the kaempferol group, cp < 0.05 vs. the quercetin group, dp < 0.05 
vs. the kaempferol-3-O-β-D-glucose group 
 
 
Figure 5: Chromatogram of standard substances (A) and sample (B); peak 1: NE, 2: DHBA, 3: DA, 4: 5-HT, 5: 5-
HIAA 
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Figure 6: Effects of kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-3-O-β-D-glucose on the 
ratio of 5-HIAA/5-HT in FST; ap < 0.05 vs. the vehicle group, bp < 0.05 vs. the kaempferol group, cp < 0.05 vs. the 
quercetin group, dp < 0.05 vs. the kaempferol-3-O-β-D-glucose group 
 
 
Figure 7: Effects of kaempferol, quercetin, kaempferol-3-O-β-D-glucose and quercetin-3-O-β-D-glucose on the 
ratio of 5-HIAA/5-HT in TST; ap < 0.05 vs. the vehicle group, bp < 0.05 vs. the kaempferol group, cp < 0.05 vs. the 
quercetin group, dp < 0.05 vs. the kaempferol-3-O-β-D-glucose groupffects of kaempferol, quercetin, kaempferol-




In the present study, the differences of anti-
depressant activities of quercetin, quercetin-3-O-
β-D-glucose, kaempferol, kaempferol-3-O-β-D-
glucose from A. venetum leaf and the possible 
mechanisms were investigated by FST, TST and 
LAT. 
 
The FST and TST are two accepted stress 
models used to evaluate the anti-depressant 
activities of drugs [1,24]. If a drug can induce the 
locomotor activity, a false positive activity in FST 
and TST will be observed and thus LAT should 
be carried out to rule out the false positive 
activity [25]. As shown in Figures 2 - 4, the 
results of FST, TST and LAT indicated that 
kaempferol, quercetin, kaempferol-3-O-β-D-
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glucose and quercetin-3-O-β-D-glucose had 
significant anti-depressant activity by reducing 
the immobility time of mice, and the inhibitory 
effects of the four flavonoids on the immobility 
time were positively related to their polarity. 
 
The monoamine theory is a widely admitted 
explanation for depression, which can lead to the 
impairment of monoaminergic functions and 
reduce the levels of monoamine 
neurotransmitters (NE, DA and 5-HT) [26]. The 
symptom of depression can be alleviated by up-
regulating the levels of monoamine 
neurotransmitters (NE, DA and 5-HT) in the CNS 
[27]. The tricyclic antidepressants, monoamine 
oxidase inhibitors and selective 5-HT reuptake 
inhibitors are now widely used in the clinic, and 
fluoxetine, a kind of selective 5-HT reuptake 
inhibitor, are more popular because of its lower 
toxicity [28,29]. So, the fluoxetine was selected 
as the positive control in the study. The ratio of 
neurotransmitter/its metabolite can be 
considered as an index of neurotransmitter 
metabolism, and the reduction of the ration 
indicates the reduction of neurotransmitter 
metabolism [29,30]. As shown in Tables 1 and 2 
and Figures 6 and 7, kaempferol, quercetin, 
kaempferol-3-O-β-D-glucose and quercetin-3-O-
β-D-glucose significantly increased the levels of 
NE, DA and 5-HT and reduced the levels of 5-
HIAA and the ratio of 5-HIAA/5-HT in the mice 
brain of FST and TST. Namely, their possible 
mechanisms of anti-depressant activity were 
related to the increase of NE, DA and 5-HT as 
well as reduction of 5-HT metabolism in mice 
brain. Moreover, the reversed effects of the four 
flavonoids on the levels of NE, DA, 5-HT and 5-






glucose and quercetin-3-O-β-D-glucose from A. 
venetum leaf have significant anti-depressant 
activity that is positively related to their polarity. 
The mechanism may be related to the increase 
of NE, DA and 5-HT as well as reduction of 5-HT 
metabolism. The study provides the evidence to 
support that A. venetum leaf has anti-depressant 
activity and the reference for studying the 
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